Kane Biotech Inks Distribution Deal with Stevens Company
The partnership expands the national availability of Health Canada licensed revyve wound-care products.
Updated on Oct. 20, 2026 in Healthcare
Live Poll
Do you believe expanded distribution partnerships between companies help provide better healthcare products in your area?
Effective October 1, 2026, Kane Biotech established a non-exclusive distribution agreement with The Stevens Company. This collaboration allows Stevens to resell revyve Antimicrobial Wound Gel and Spray across Canada.
Why it matters
The agreement serves as a key step in Kane Biotech's Canadian distribution strategy to broaden the market reach of its wound-care products. It leverages the established sales and distribution network of The Stevens Company to support clinical product access.
The Stevens Company will manage distribution through facilities in Vancouver, Calgary, Saskatoon, Winnipeg, Brampton, Montreal, and Halifax. Inventory includes 1 oz and 3 oz formats of gel and a 5 oz spray.
The players
Kane Biotech
Headquartered in Winnipeg, Manitoba, this biotechnology company specializes in the development and commercialization of technologies to prevent and disperse biofilms.
The Stevens Company
Founded in 1830, this distributor provides medical and surgical supplies to healthcare providers across Canada through a national network of regional centres.
The details
The partnership combines Kane's clinical expertise with Stevens' extensive sales network to move Health Canada licensed products into the wider market. Stevens operates a logistics chain that now includes revyve wound-care solutions following a history of corporate integration.
Timeline
The distribution agreement became effective on October 1, 2026.
The companies officially announced the partnership on October 20, 2026.
Market Landscape
This deal continues the industry consolidation seen at The Stevens Company, which integrated Schaan Healthcare Products and CB Medical in 2024 and TRH Services Inc. in early 2026. These strategic expansions position Stevens to capture larger shares of the national medical supply market.
Healthcare providers across Canada will see increased access to Health Canada licensed revyve products through established supply channels. This integration aims to streamline the procurement process for clinical wound-care solutions at local facilities.
The takeaway
This partnership highlights the trend of smaller biotechnology firms partnering with established legacy distributors to scale operations. It signals a shift toward broader availability of specialized medical gel and spray products in the Canadian market.
Further reading
Explore more developments in the Canada Healthcare sector.
More information
Review the full specifications for the company's offerings at the Kane Biotech product information page.
Live Poll
Do you believe expanded distribution partnerships between companies help provide better healthcare products in your area?
